Office of the Commissioner of Lobbying of CanadaOffice of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

All Monthly Communication Reports for Vertex Pharmaceuticals (Canada) Incorporated

Michael Siauw, General Manager – Canada (Corporation)

Learn more...

Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.

Note: Monthly Communication Reports are due on the 15th day of each month for communications that took place in the previous month.

Results below are sorted by posted date, beginning with the most recent.

Results null-null of 29

  • Vertex Pharmaceuticals (Canada) Incorporated
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Rodrigo Arancibia, Senior Director | Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    • Ritu Banerjee, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Budget, Economic Development, Federal-Provincial Relations
    Communication date: 2025-03-31
    Posted date: 2025-04-30
    Communication number: 366162-635417 View monthly communication report
  • Vertex Pharmaceuticals (Canada) Incorporated
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sarah Polowin, Director of Parliamentary Affairs | Senate of Canada
    • Mohamed-Iqbal Ravalia, Senator | Senate of Canada

    Subject Matter of the communication: Health
    Communication date: 2024-06-20
    Posted date: 2024-07-11
    Communication number: 366162-610223 View monthly communication report
  • Vertex Pharmaceuticals (Canada) Incorporated
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Nicolas Thibodeau, Parliamentary Affairs Advisor | Senate of Canada
    • Marie-Françoise Mégie, Senator | Senate of Canada

    Subject Matter of the communication: Health
    Communication date: 2024-06-19
    Posted date: 2024-07-11
    Communication number: 366162-610220 View monthly communication report
  • Vertex Pharmaceuticals (Canada) Incorporated
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Jed Graham, Policy Advisor | Health Canada (HC)
    • Sandenga Yeba, Senior Policy Advisor | Office of the Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Health, Science and Technology, Research and Development
    Communication date: 2023-07-05
    Posted date: 2023-08-15
    Communication number: 366162-574953 View monthly communication report
  • Vertex Pharmaceuticals (Canada) Incorporated
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Christine Ung, Policy Advisor | Health Canada (HC)
    • Josee Leblanc, Senior Policy Advisor | Health Canada (HC)
    • Andrew Taylor, Senior Policy Advisor | Health Canada (HC)
    • Daniel MacDonald, Director General, Drugs for Rare Diseases | Strategic Policy Branch | Health Canada (HC)

    Subject Matter of the communication: Health, Science and Technology, Research and Development
    Communication date: 2023-07-04
    Posted date: 2023-08-15
    Communication number: 366162-574946 View monthly communication report
  • Vertex Pharmaceuticals (Canada) Incorporated
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • caroline menard, manager | Innovation, Science and Economic Development Canada (ISED)
    • Rodrigo Arancibia, Director | Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    • Darryl Patterson, Director General | Innovation, Science and Economic Development Canada (ISED)
    • Ritu Banerjee, Assistant Deputy Minister | Director General's Office | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Science and Technology, Research and Development
    Communication date: 2023-07-04
    Posted date: 2023-08-15
    Communication number: 366162-574853 View monthly communication report
  • Vertex Pharmaceuticals (Canada) Incorporated
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Michael Rosu-Miles, Director | Health Canada (HC)
    • Aswin Hari, Biologist/Evaluator | Health Canada (HC)
    • Omar Tounekti, Manager, Gene Therapies Division | Health Canada (HC)
    • Martin Nemec, Senior Biologist/Evaluator | Health Canada (HC)
    • Emily Griffiths, Subject Matter / Technical Specialist | Health Canada (HC)
    • Denis Arsenault, Manager - Policy Development | Health Canada (HC)

    Subject Matter of the communication: Health, Science and Technology, Research and Development
    Communication date: 2022-08-17
    Posted date: 2022-09-09
    Communication number: 366162-540988 View monthly communication report
  • Vertex Pharmaceuticals (Canada) Incorporated
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Rodrigo Arancibia, Director | Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    • Darryl Patterson, Director General | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Science and Technology, Research and Development
    Communication date: 2022-05-31
    Posted date: 2022-06-15
    Communication number: 366162-533098 View monthly communication report
  • Vertex Pharmaceuticals (Canada) Incorporated
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Benoit Leduc, Manager, Life Science Industries Directorate | Manufacturing and Life Sciences Branch | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Intellectual Property, Science and Technology, Research and Development, Economic Development
    Communication date: 2021-12-03
    Posted date: 2022-01-05
    Communication number: 366162-518729 View monthly communication report
  • Vertex Pharmaceuticals (Canada) Incorporated
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Melissa Lantsman, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2021-11-19
    Posted date: 2021-12-01
    Communication number: 366162-516348 View monthly communication report
  • Vertex Pharmaceuticals (Canada) Incorporated
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Adam Vaughan, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2021-06-30
    Posted date: 2021-07-28
    Communication number: 366162-511846 View monthly communication report
  • Vertex Pharmaceuticals (Canada) Incorporated
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Michael Cooper, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2021-06-04
    Posted date: 2021-07-15
    Communication number: 366162-509519 View monthly communication report
  • Vertex Pharmaceuticals (Canada) Incorporated
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Tom Kmiec, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2021-04-15
    Posted date: 2021-05-15
    Communication number: 366162-503409 View monthly communication report
  • Vertex Pharmaceuticals (Canada) Incorporated
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Alupa A. Clarke, Quebec representative at the Office of the Official Opposition | House of Commons
    • Andrew Swidzinski, Advisor, Office of the Official Opposition | House of Commons

    Subject Matter of the communication: Health, Intellectual Property, Research and Development
    Communication date: 2021-02-22
    Posted date: 2021-03-15
    Communication number: 366162-496963 View monthly communication report
  • Vertex Pharmaceuticals (Canada) Incorporated
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sabina Saini, Chief of Staff | Minister's Office | Health Canada (HC)
    • Kathryn Nowers, Director of Policy | Minister's Office | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2020-11-13
    Posted date: 2020-12-15
    Communication number: 366162-488847 View monthly communication report
  • Vertex Pharmaceuticals (Canada) Incorporated
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Randeep Sarai, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Intellectual Property
    Communication date: 2020-10-23
    Posted date: 2020-11-16
    Communication number: 366162-485980 View monthly communication report
  • Vertex Pharmaceuticals (Canada) Incorporated
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Michael Cooper, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2020-10-13
    Posted date: 2020-11-16
    Communication number: 366162-485979 View monthly communication report
  • Vertex Pharmaceuticals (Canada) Incorporated
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • James Cumming, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Intellectual Property
    Communication date: 2020-10-13
    Posted date: 2020-11-16
    Communication number: 366162-485978 View monthly communication report
  • Vertex Pharmaceuticals (Canada) Incorporated
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Matthew Solheim, Policy Advisor | Office of the Leader of the Opposition | House of Commons

    Subject Matter of the communication: Health, Intellectual Property
    Communication date: 2020-10-08
    Posted date: 2020-11-16
    Communication number: 366162-485977 View monthly communication report
  • Vertex Pharmaceuticals (Canada) Incorporated
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sean Casey, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Intellectual Property
    Communication date: 2020-09-28
    Posted date: 2020-10-15
    Communication number: 366162-483240 View monthly communication report
  • Vertex Pharmaceuticals (Canada) Incorporated
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Luc Thériault, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Intellectual Property
    Communication date: 2020-09-21
    Posted date: 2020-10-15
    Communication number: 366162-483239 View monthly communication report
  • Vertex Pharmaceuticals (Canada) Incorporated
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Adam Vaughan, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Intellectual Property
    Communication date: 2020-09-16
    Posted date: 2020-10-15
    Communication number: 366162-483238 View monthly communication report
  • Vertex Pharmaceuticals (Canada) Incorporated
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Gérard Deltell, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Intellectual Property
    Communication date: 2020-09-14
    Posted date: 2020-10-15
    Communication number: 366162-483235 View monthly communication report
  • Vertex Pharmaceuticals (Canada) Incorporated
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)

    Subject Matter of the communication: Health, Intellectual Property
    Communication date: 2020-08-12
    Posted date: 2020-09-09
    Communication number: 366162-481152 View monthly communication report
  • Vertex Pharmaceuticals (Canada) Incorporated
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Matt Jeneroux, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Intellectual Property
    Communication date: 2020-08-06
    Posted date: 2020-09-09
    Communication number: 366162-481153 View monthly communication report
  • Vertex Pharmaceuticals (Canada) Incorporated
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • David Yurdiga, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2020-06-26
    Posted date: 2020-07-10
    Communication number: 366162-476603 View monthly communication report
  • Vertex Pharmaceuticals (Canada) Incorporated
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sabina Saini, Chief of Staff | Minister's Office | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2020-06-09
    Posted date: 2020-07-10
    Communication number: 366162-476602 View monthly communication report
  • Vertex Pharmaceuticals (Canada) Incorporated
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Elizabeth May, M.P. Saanich - Gulf Islands | Office of Elizabeth May, O.C., M.P. Saanich - Gulf Islands | Bureau de Circonscription, Elizabeth May, Députée Saanich - Gulf Islands | House of Commons

    Subject Matter of the communication: Health, Intellectual Property
    Communication date: 2020-05-22
    Posted date: 2020-06-08
    Communication number: 366162-474540 View monthly communication report
  • Vertex Pharmaceuticals (Canada) Incorporated
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sabina Saini, Chief of Staff/Chef du Cabinet | Office of the Honourable Patty Hajdu, Minister of Health/Bureau de l’honorable Patty Hajdu, ministre de la Santé | Health Canada (HC)

    Subject Matter of the communication: Health, Intellectual Property
    Communication date: 2020-05-12
    Posted date: 2020-06-08
    Communication number: 366162-474539 View monthly communication report
Date Modified: